使用实时连续血糖监测减少普通病房住院患者低血糖:血糖遥测系统随机临床试验
该随机临床试验纳入72例低血糖高风险胰岛素治疗的2型糖尿病住院患者,比较实时连续血糖监测联合血糖遥测系统(RT-CGM/GTS)与床旁血糖检测对住院低血糖的影响。结果显示RT-CGM/GTS组每例患者低血糖事件更少,但夜间低血糖、目标范围内时间及高于范围时间两组无差异。结论认为RT-CGM/GTS可减少住院高风险胰岛素治疗的2型糖尿病患者的低血糖。
要点
- RT-CGM/GTS组每例患者低血糖事件(<70 mg/dL)少于床旁血糖检测组。
- RT-CGM/GTS组每例患者临床显著低血糖事件(<54 mg/dL)少于床旁血糖检测组。
- 两组夜间低血糖及目标范围内时间无差异。
核心结论
- RT-CGM/GTS可减少住院高风险胰岛素治疗的2型糖尿病患者的低血糖。
研究设计与样本
- 随机临床试验,纳入低血糖高风险的胰岛素治疗2型糖尿病患者,随机分为RT-CGM/GTS组或床旁血糖检测组。
- 本次期中分析共纳入72例参与者,RT-CGM/GTS组36例,床旁血糖检测组36例。
主要发现
- RT-CGM/GTS组每例患者低血糖事件(<70 mg/dL)为0.67(95%CI 0.34-1.30),床旁血糖检测组为1.69(95%CI 1.11-2.58),P=0.024。
- RT-CGM/GTS组每例患者临床显著低血糖事件(<54 mg/dL)为0.08(95%CI 0.03-0.26),床旁血糖检测组为0.75(95%CI 0.51-1.09),P=0.003。
- RT-CGM/GTS组低于范围<70 mg/dL的时间百分比为0.40%(95%CI 0.18-0.92%),床旁血糖检测组为1.88%(95%CI 1.26-2.81%),P=0.002。
- RT-CGM/GTS组低于范围<54 mg/dL的时间百分比为0.05%(95%CI 0.01-0.43%),床旁血糖检测组为0.82%(95%CI 0.47-1.43%),P=0.017。
- 两组夜间低血糖、目标范围内时间70-180 mg/dL、高于范围>180-250 mg/dL及>250 mg/dL的时间均无差异。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Use of real-time continuous glucose monitoring (RT-CGM) systems in the inpatient setting is considered investigational. The objective of this study was to evaluate whether RT-CGM, using the glucose telemetry system (GTS), can prevent hypoglycemia in the general wards. RESEARCH DESIGN AND METHODS: In a randomized clinical trial, insulin-treated patients with type 2 diabetes at high risk for hypoglycemia were recruited. Participants were randomized to RT-CGM/GTS or point-of-care (POC) blood glucose testing. The primary outcome was difference in inpatient hypoglycemia. RESULTS: Seventy-two participants were included in this interim analysis, 36 in the RT-CGM/GTS group and 36 in the POC group. The RT-CGM/GTS group experienced fewer hypoglycemic events (<70 mg/dL) per patient (0.67 [95% CI 0.34-1.30] vs. 1.69 [1.11-2.58], P = 0.024), fewer clinically significant hypoglycemic events (<54 mg/dL) per patient (0.08 [0.03-0.26] vs. 0.75 [0.51-1.09], P = 0.003), and a lower percentage of time spent below range <70 mg/dL (0.40% [0.18-0.92%] vs. 1.88% [1.26-2.81%], P = 0.002) and <54 mg/dL (0.05% [0.01-0.43%] vs. 0.82% [0.47-1.43%], P = 0.017) compared with the POC group. No differences in nocturnal hypoglycemia, time in range 70-180 mg/dL, and time above range >180-250 mg/dL and >250 mg/dL were found between the groups. The RT-CGM/GTS group had no prolonged hypoglycemia compared with 0.20 episodes <54 mg/dL and 0.40 episodes <70 mg/dL per patient in the POC group. CONCLUSIONS: RT-CGM/GTS can decrease hypoglycemia among hospitalized high-risk insulin-treated patients with type 2 diabetes.
引用
- Singh LG, Satyarengga M, Marcano I, et al. Reducing Inpatient Hypoglycemia in the General Wards Using Real-time Continuous Glucose Monitoring: The Glucose Telemetry System, a Randomized Clinical Trial. Diabetes Care. 2020. PMID: 32759361. doi:10.2337/dc20-0840
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。